期刊文献+

甲型流感的抗感染药物治疗

Anti-infective medicine for influenza A
原文传递
导出
摘要 在甲型H1N1流感中,准确判断患者病情的严重程度和继发性感染的可能,是合理使用抗病毒药物或抗菌药物治疗的关键环节。流感最常见的继发性感染病原为肺炎链球菌,A、C及G组链球菌,流感嗜血杆菌和金黄色葡萄球菌等,常造成病情恶化甚至死亡。在充分考虑抗菌药物治疗过程中可能出现的甲氧西林耐药金葡菌和难辨梭菌相关性腹泻的前提下,本文对甲型流感继发性感染的用药提出了具体治疗方案。 Accurate assessment of severity and risk of secondary infections of influenza A (H1N1) is undoubtedly the key critical process when making decisions about antiviral and antibiotic therapy.Secondary infections with Streptococcus pneumoniae,Streptococcus A,C and G group,Haemophilus influenzae and Staphylococcus aureus are likely to be the important causes of morbidity and mortality.The article considered the risk of Clostridium difficile-associated diarrhoea (CDAD) and the emergence of methicillin-resistant Staphylococcus aureus (MRSA),and put forward the potentially useful antibiotic regimens for bacterial infections in influenza A (H1N1) and seasonal influenza.
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2010年第1期1-4,共4页 Chinese Journal of New Drugs and Clinical Remedies
关键词 流感 抗病毒药 抗菌药 难辨梭菌相关性腹泻 甲氧西林耐药金葡菌 influenza human antiviral agents anti-bacterial agents Clostridium difficile-associated diarrhea methicillin-resistant Staphylococcus aureus
  • 相关文献

参考文献12

  • 1Department of Health. Swine flu clinical package [EB/OL]. [2009 -7 -28]. http ://www.dh.gov.uk/en/Publicationsandstatisties/PolicyAndGuidance/DH_100941.
  • 2British Infection Society, British Thoracic Society and Health Protection Agency in collaboration with the Department of Health. Clinical management of patients with an influenza-like illness during an influenza pandemic[J]. Thorax, 2007, 62 Suppl 1 : 1-46.
  • 3国家卫生部.甲型H1N1流感诊疗方案(2009年10月第3版)[EB/OL]. [2009-11 - 16]. http :// www.moh.gov.cn/publicfiles/ business/htmlfiles/mohyzs.
  • 4BARLOW GD, BSAC Council. Swine flu and antibiotics[J]. J Antimicrob Chemother, 2009, 64(5): 889-894.
  • 5Centers for Disease Control and Prevention. Updated Interim Recommendations for the Use of Antiviral Medications in the Treatment and Prevention of Influenza for the 2009-2010 Season [EB/OL]. [2009-10-12]. http ://www.cdc.gov/mmwr/preview/mmwrhtml/ mm5827a4.htm.
  • 6DUBBERKE ER, RESKS KA, YAN Y, et oi. Clostridium difficile-associated disease in a setting of endemicity: identification of novel risk factors[J]. Clin Infect Dis, 2007, 45 (12): 1543-1549.
  • 7MONNET DL, MACKENZIE FM, LoPEZ-LOZANO JM, et al. Antimicrobial drug use and methieillin-resistant Staphylococcus aureus[J]. Emerg Infect Dis, 2004, 10(8): 1432-1441.
  • 8BAXTER R, RAY GT, FIREMAN BH. Case-control study of antibiotic use and subsequent Clostridium difficile-associated diarrhea in hospitalized patients [J]. Infect Control Hosp Epidemiol, 2008,29 ( 1 ) :44-50.
  • 9BARLOW G, NATHWANI D, MYERS E, et ol. Identifying barriers to the rapid administration of appropriate antibiotics in community-acquired pneumonia[J]. J Antimicrob Chemother, 2008, 61(2): 442-451.
  • 10CHOWELL G, BERTOZZI SM, COLCHERO MA, et al. Severe respiratory disease concurrent with the circulation of H1N1 influenza [J]. NEngl J Med, 2009, 361 (7):674-679.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部